3 research outputs found

    The validity of biomarkers as surrogate endpoints in Alzheimer’s disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES)

    No full text

    Neuropeptides in Alzheimer’s Disease: An Update

    No full text
    corecore